•  
  •  
  •  
  •  

2026-02-23 17:30:17

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Olectra Greentech Bags ₹1,800 Cr Electric Bus Order
  • Urban Company's InstaHelp crosses 50,000 daily bookings in less than 1 year of launch
  • LTM Wins a $100million Deal with European MedTech
  • TCS and ServiceNow partner to accelerate large-scale AI adoption for enterprises
  • Synthiko Foils Ltd is now Belding India Ltd

Keywords Selected:  Biotech

IPO News

  • Concord Biotech Limited's IPO to open on Friday, 4th August, 2023, sets price band at ₹705 to ₹741 per Equity Share
  • Windlas Biotech Ltd posts consolidated PAT of Rs. 11.44 crores in Q4FY23
  • Ahmedabad-based Concord Biotech gets SEBI nod for IPO
  • Rare Enterprises and Quadria Capital-backed Concord Biotech files DRHP for IPO

Stock Report

  • Indo US Bio-Tech Ltd Q3 FY2025-26 net profit lower at Rs. 2.99 crore
  • Rossari Biotech Ltd Q3FY26 consolidated profit at Rs. 32.77 crores
  • Medicamen Biotech Ltd gets EU approval for Paracetamol from Danish Medicine Authority
  • Vivo Bio Tech Ltd receives GLP compliance from NGCMA
  • Titan Biotech Ltd fixes Feb 20, 2026 as record date for 5:1 stock split
  • Fermenta ranked among India's Best Workplaces™ in Pharmaceuticals, Healthcare & Biotech by Great Place to Work®
  • Fermenta Board approves INR 110 Crore Capex at Dahej for Plant-based Vitamin D3, Green Chemistry Enzyme, and Vitamin D3 Derivatives
  • Coastal Biotech Pvt Ltd receives allocation for Supply of Ethanol to OMC's under Ethanol Blended Petrol Programme
  • Rossari Biotech Ltd Q2 FY2025-26 consolidated PAT increases to Rs. 36.87 crores
  • Concord Biotech Ltd completes NAFDAC inspection successfully
  • Fermenta Biotech Limited Certified as a Great Place to Work®
  • Fermenta Board approves sale of Environmental Solutions Business to Wholly Owned Subsidiary
  • Fermenta Granted Process Patent for Plant-Based Vitamin D3
  • Concord Biotech Limited completes EUGMP inspection at its API facility
  • Vivo Bio Tech Ltd secures landmark Pre-Clinical Testing Contract Valued at ₹10.75 Crores
  • Fermenta announces Granting of CEP by EDQM for VITADEE™ 100 SD, Enabling Accelerated Global Growth
  • Concord Biotech Ltd successfully completes Russian GMP insepction at its API facility
  • Shilpa Medicare Backs US Biotech Alveolus Bio to Accelerate Next‐Gen Lung Disease Therapies
  • Rossari Biotech Ltd posts consolidated PAT of Rs. 33.59 crores in Q1 FY26
  • Concord Biotech Ltd announces successful completion EU GMP inspection at its API facility
  • Fermenta Signs Strategic MoU with NIFTEM-T to Strengthen India's Food Fortification Landscape
  • Indo Us Bio Tech Ltd signs MOU with ICAR-IARI
  • Concord Biotech Limited receives EIR from USFDA for API facility at Dholka
  • USFDA Inspection at Concord Biotech Ltd's API facility at Dholka

Latest Post

  • Olectra Greentech Bags ₹1,800 Cr Electric Bus Order
  • Urban Company's InstaHelp crosses 50,000 daily bookings in less than 1 year of launch
  • LTM Wins a $100million Deal with European MedTech
  • TCS and ServiceNow partner to accelerate large-scale AI adoption for enterprises
  • Synthiko Foils Ltd is now Belding India Ltd


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025